Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
The Gm & Cheshire Life Sciences Fund L.P investment portfolio
The Gm & Cheshire Life Sciences Fund L.P has made numerous investments in companies such as Ovo Biomanufacturing, Cancertain, and Monument Therapeutics within the Biotech sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Cancertain Limited CANCERTAIN LIMITED provides a specialized clinical test, the Cancertain™ Assay, which utilizes advanced 3D cell culture techniques to identify the most effective personalized cancer treatment for individual patients. This service aims to guide treatment decisions for patients, physicians, and oncologists by recommending optimal therapies to improve patient quality of life and treatment efficacy. | Health TechBiotechB2B | Confirmed | 2025-03-29 |
| Monument Therapeutics Limited | Healthcare & Life Sciences | Confirmed | 2026-02-21 |
Shareholding changes (3)
The Gm & Cheshire Life Sciences Fund L.P's positions across portfolio companies2024
- A ORDINARY 0 → 30,000
2023
- A ORDINARY 962,538 → 1,112,538
Articles (2)
- Coventry biotech Ovo Biomanufacturing secures £229.6k to optimize vaccine production9 May 2026Ovo Biomanufacturing
- 22 Apr 2026